Who founded Replicate Bioscience?

Replicate Bioscience was founded by Nathaniel Wang, Andy Geall, Herbert Kim Lyerly, Zachary Hartman in 2021.

Who are Replicate Bioscience's investors?

Replicate Bioscience's investors include ATP.

How much funding has Replicate Bioscience raised?

Replicate Bioscience has disclosed $20M raised across 1 round.

Where is Replicate Bioscience headquartered?

Replicate Bioscience is headquartered in San Diego, US.

Replicate Bioscience

San Diego, US · Founded 2021 · Delaware corporation · 23 employees on LinkedIn · 1 known investors

Find your way into Replicate Bioscience

Paths you didn't know you had: your email and LinkedIn already hold routes to the Replicate Bioscience team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Replicate Bioscience develops self-replicating RNA (srRNA) vector therapeutics that use cells' own machinery to produce sustained protein expression, aiming for durable therapeutic effects. Its pipeline targets several therapeutic areas including infectious disease, oncology, and autoimmune disorders.

Biotech Deep Tech Healthtech

Founders & leadership

Replicate Bioscience was founded in 2021 by Nathaniel Wang, Andy Geall, Herbert Kim Lyerly, and Zachary Hartman.

Nathaniel Wang Chief Executive Officer and Co-FounderNathaniel Wang is co-founder of Replicate Bioscience and brings over 15 years of experience in immunology and drug development across biotech and pharma, with expertise in synthetic self-replicating RNA technologies and their applications in therapeutics. He has held leadership roles in business strategy, corporate development, and team management, and is the author of multiple scientific publications and patents in the field.

Andy Geall Co-founderWith over 20 years of experience in mRNA vaccines and nucleic acid delivery, he has led research translation to clinical development, managed multidisciplinary teams, and scaled manufacturing processes to GMP standards.

Herbert Kim LyerlyCo-founderCMO & Founder at Trio Pharmaceuticals

Zachary HartmanCo-founder

Joseph YanchikNamed on SEC filingVenture Partner at Apple Tree Venture Management Llc

Board

Seth HarrisonBoard directorFounder and Managing Partner at Apple Tree Venture Management Llc

Michael EhlersCo-Founder and Board MemberVenture Partner at Apple Tree Venture Management Llc

Investors · 1

ATP✓ confirmed by Replicate BioscienceAustin

How we know: the company's own site · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$20M disclosed across 1 round · 2021

▶$20MraisedMar 2022 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Nathaniel WangExecutive Officer, Director
Seth HarrisonDirector
Joseph YanchikDirector
Michael EhlersExecutive Officer, Director

Offering amount: $53M
Amount sold: $20M
First sale: Feb 2021
Incorporated: Corporation, Delaware, 2021
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

Life BiosciencesLife Biosciences is a biopharmaceutical company developing therapies focused on aging and age-related diseases, working across gene therapy and neuroscience programs. It advances drug candidates from discovery through clinical development.

Companies working in the same space as Replicate Bioscience.

Frequently asked questions

What does Replicate Bioscience do?: Replicate Bioscience develops self-replicating RNA (srRNA) vector therapeutics that use cells' own machinery to produce sustained protein expression, aiming for durable therapeutic effects. Its pipeline targets several therapeutic areas including infectious disease, oncology, and autoimmune disorders.
Who founded Replicate Bioscience?: Replicate Bioscience was founded by Nathaniel Wang, Andy Geall, Herbert Kim Lyerly, Zachary Hartman in 2021.
Who are Replicate Bioscience's investors?: Replicate Bioscience's investors include ATP.
How much funding has Replicate Bioscience raised?: Replicate Bioscience has disclosed $20M raised across 1 round.
Where is Replicate Bioscience headquartered?: Replicate Bioscience is headquartered in San Diego, US.